SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized lupus drug study halted early
Disease control TerminatedThis study aimed to see if adding a drug called voclosporin to a standard lupus medication (mycophenolate mofetil, or MMF) could better control disease activity. It tested this in a small group of adults with active, non-organ-threatening lupus, grouping them by their immune syst…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New drug trial aims to tame rogue immune system in lupus patients
Disease control TerminatedThis Phase 3 trial tested whether a drug called telitacicept could better control disease activity in people with moderate-to-severe systemic lupus erythematosus (SLE). Participants, who were already taking standard lupus medications, received either telitacicept or a placebo for…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC